Prevention and management of ovarian hyperstimulation syndrome

被引:25
|
作者
Chen, Chin-Der
Chen, Shee-Uan
Yang, Yu-Shih [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Obstet & Gynaecol, Taipei, Taiwan
关键词
ovarian hyperstimulation syndrome; complications; prevention; management; IN-VITRO FERTILIZATION; ENDOTHELIAL GROWTH-FACTOR; APPROACH AGONIST TRIGGER; FINAL OOCYTE MATURATION; GNRH AGONIST; INTRAVENOUS ALBUMIN; CYCLES; ASCITES; WOMEN; RISK;
D O I
10.1016/j.bpobgyn.2012.04.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian hyperstimulation syndrome is a relatively common complication of ovarian stimulation and can be life-threatening. The pathophysiology of ovarian hyperstimulation syndrome is characterised by increased capillary permeability, leading to leakage of fluid from the vascular compartment, with third space fluid accumulation and intravascular dehydration. The combined use of a gonadotrophin-releasing hormone antagonist protocol with gonadotrophin-releasing hormone agonist triggering and oocyte and embryo freezing has considerable promise in preventing ovarian hyperstimulation syndrome. Women with severe ovarian hyperstimulation syndrome require hospitalisation for more careful monitoring and treatment. Transvaginal paracentesis can be used as an outpatient treatment to prevent the need for hospitalisation. The inhibition of vascular permeability seems to be a novel therapeutic approach to preventing and treating ovarian hyperstimulation syndrome. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:817 / 827
页数:11
相关论文
共 50 条
  • [41] CABERGOLINE IN PREVENTION AND TREATMENT OF OVARIAN HYPERSTIMULATION SYNDROME
    Dosedla, Erik
    Gasparova, Petra
    Ballova, Zuzana
    Sitas, Martina
    Turcsanyiova, Zuzana
    Calda, Pavel
    AKTUALNI GYNEKOLOGIE A PORODNICTVI, 2023, 15 : 49 - 54
  • [42] Pathophysiology, treatment and prevention of ovarian hyperstimulation syndrome
    Kwik, Michele
    Maxwell, Elizabeth
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2016, 28 (04) : 236 - 241
  • [43] The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
    Hosseini, Marzieh Agha
    Aleyasin, Ashraf
    Mahdavi, Atossa
    Nezami, Romina
    Safdarian, Leila
    Fallahi, Parvin
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2011, 36 (03) : 207 - 212
  • [44] Volume expanders for the prevention of ovarian hyperstimulation syndrome
    Youssef, Mohamed A.
    Mourad, Selma
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (08):
  • [45] Use of cabergoline for the ovarian hyperstimulation syndrome prevention
    Merino, V. Verdu
    Gonzalez-Villafanez, V.
    Alarcon, M.
    Lopez, L.
    Lopez-Yanez, L.
    de Segura, R. Gomez
    Arenas, J. M. Bajo
    HUMAN REPRODUCTION, 2007, 22 : I146 - I147
  • [46] Diagnosis and Management of Ovarian Hyperstimulation Syndrome
    Shmorgun, Doron
    Claman, Paul
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2023, 45 (07) : 539 - 540
  • [47] THE MANAGEMENT OF SEVERE OVARIAN HYPERSTIMULATION SYNDROME
    JENKINS, JM
    MATHUR, RS
    COOKE, ID
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1995, 102 (01): : 2 - 5
  • [48] THE MANAGEMENT OF SEVERE OVARIAN HYPERSTIMULATION SYNDROME
    DAWSON, WG
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1995, 102 (07): : 585 - 585
  • [49] Update on management of ovarian hyperstimulation syndrome
    Chen, Chin-Der
    Wu, Mng Ying
    Chao, Kuang-Han
    Lien, Yih-Ron
    Chen, Shee-Uan
    Yang, Yu-Shih
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2011, 50 (01): : 2 - 10
  • [50] Ovarian Hyperstimulation Syndrome prophylaxis and management
    El-Sahwi, S.
    PROCEEDINGS OF THE 14TH WORLD CONGRESS ON IN VITRO FERTILIZATION & 3RD WORLD CONGRESS ON IN VITRO MATURATION, 2007, : 299 - 305